Launch of the Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C and STIs, 2026–2030
Note: This description is sourced from the original post. We recommend reading the full post on the event site.
The WHO Department of HIV, Tuberculosis, Hepatitis and sexually transmitted infections (STIs), in collaboration with the AMR Department, invites you to a webinar to launch the Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C and STIs, 2026–2030. This landmark Framework unites HIV, hepatitis B and C, and STIs under a single, integrated vision for drug resistance prevention, monitoring, and response. It provides a strategic roadmap to guide countries, partners, communities and stakeholders in strengthening national and global efforts to address the growing threat of drug resistance. The launch will take place during WAAW 2025, aligning with this year’s theme, “Act Now: Protect Our Present, Secure Our Future.” Join us for this flagship event as WHO and partners present the Framework and discuss its role in protecting global health gains and building preparedness against emerging threats.